These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 9794366

  • 1. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
    McCluskie MJ, Davis HL.
    J Immunol; 1998 Nov 01; 161(9):4463-6. PubMed ID: 9794366
    [Abstract] [Full Text] [Related]

  • 2. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G, Benjamin P, Soita H, Babiuk LA.
    Vaccine; 2008 May 23; 26(22):2680-8. PubMed ID: 18430493
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G, Cheng Y, Wang Z, Hu Y, Zhang X, Wu M, Chen Z, Shi B, Sun S, Shen Y, Chen EJ, Yao X, Wen Y, Yuan Z.
    Vaccine; 2009 Dec 10; 28(1):187-94. PubMed ID: 19789093
    [Abstract] [Full Text] [Related]

  • 8. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J, Adamsson J, Anjuère F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M, Lehner T, Lindblad M, Nygren E, Raghavan S, Sanchez J, Stanford M, Sun JB, Svennerholm AM, Tengvall S.
    Immunol Lett; 2005 Mar 15; 97(2):181-8. PubMed ID: 15752556
    [Abstract] [Full Text] [Related]

  • 9. Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
    Li Y, Kandimalla ER, Yu D, Agrawal S.
    Int Immunopharmacol; 2005 Jun 15; 5(6):981-91. PubMed ID: 15829414
    [Abstract] [Full Text] [Related]

  • 10. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.
    Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, Jirillo E, McGhee JR.
    J Immunol; 1999 Jan 01; 162(1):114-21. PubMed ID: 9886376
    [Abstract] [Full Text] [Related]

  • 11. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May 01; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES, Park SA, Kim SH, Cho YJ, Ahn BY, Ahn BC, Lee NG.
    FEMS Immunol Med Microbiol; 2007 Dec 01; 51(3):496-504. PubMed ID: 17877731
    [Abstract] [Full Text] [Related]

  • 13. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF, Wang CC, Wu TC, Wu KG, Lee CC, Peng HJ.
    J Pediatr Gastroenterol Nutr; 2008 Mar 01; 46(3):262-71. PubMed ID: 18376242
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity.
    Wang D, Kandimalla ER, Yu D, Tang JX, Agrawal S.
    Vaccine; 2005 Apr 08; 23(20):2614-22. PubMed ID: 15780444
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
    Vadolas J, Davies JK, Wright PJ, Strugnell RA.
    Eur J Immunol; 1995 Apr 08; 25(4):969-75. PubMed ID: 7737300
    [Abstract] [Full Text] [Related]

  • 20. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM.
    J Immunol; 1998 Jan 15; 160(2):870-6. PubMed ID: 9551923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.